WHO ICTRP trial
Pentoxifylline in prevention of amphotericin-induced nephrotoxicity and…
IRCT2016071328901N1 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT2016071328901N1 |
|---|---|
| Public title | Pentoxifylline in prevention of amphotericin-induced nephrotoxicity and electrolytes imbalances |
| Scientific title | Pentoxifylline in prevention of amphotericin-induced nephrotoxicity and electrolytes imbalances in patients hospitalized in university affiliated hospital, Sayyed-o-Shohada, 2016-2017: a randomized, double blinded, placebo-controlled clinical trial |
| Primary sponsor | Isfahan University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 2-3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Fungal infections. Unspecified mycosis;Unspecified mycosis |
| Interventions | Intervention 1: Control group: Placebo 800 mg/day, oral, administered concomitantly with Amphotericin (from the beginning till the final dose of Amphotericin). Intervention 2: Intervention group: Pentoxiphylline 800 mg/day, oral… |
| Registration date | Oct 6, 2016 |
| Target size | 60 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: